Interleukin-18 in cardiomyocyte: A novel therapeutic target for attenuating cardiac remodeling. Response.

Okuhara, Yoshitaka; Yokoe, Shunichi; Asahi, Michio; Okamura, Haruki; Masuyama, Tohru; Hirotani, Shinichi

Okuhara, Yoshitaka; Yokoe, Shunichi; Asahi, Michio; Okamura, Haruki; Masuyama, Tohru; Hirotani, Shinichi.

Afiliação

Okuhara Y; Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Yokoe S; Department of Pharmacology, Faculty of Medicine, Osaka Medical College, Osaka, Japan.
Asahi M; Department of Pharmacology, Faculty of Medicine, Osaka Medical College, Osaka, Japan.
Okamura H; Laboratory of Tumor Immunology and Cell Therapy, Hyogo College of Medicine, Nishinomiya, Japan.
Masuyama T; Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Hirotani S; Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan. Electronic address: hirotani@hyo-med.ac.jp.

Int J Cardiol ; 266: 221, 2018 09 01.

Article em En | MEDLINE | ID: mdl-29887453

Assuntos

Interleucina-18; Miócitos Cardíacos; Humanos; Interleucina-6; Remodelação Ventricular

Palavras-chave

Cardiac remodeling; IL-18; Sepsis-induced cardiac dysfunction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-18 / Miócitos Cardíacos Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google